Ligand Pharmaceuticals (LGND) Income from Non-Controlling Interests (2014 - 2015)
Ligand Pharmaceuticals' (LGND) quarterly Income from Non-Controlling Interests came in at -$1.5 million in Q2 2015, down 405.59% year-on-year from $502958.0 in Q2 2014, and down 82.33% quarter-over-quarter from -$843000.0 in Q1 2015.
Ligand Pharmaceuticals (LGND) Income from Non-Controlling Interests (2014 - 2015) Analysis & Trends
Ligand Pharmaceuticals has disclosed Income from Non-Controlling Interests across 2 years of filings, most recently posting -$1.5 million for Q2 2015.
- Income from Non-Controlling Interests for Q2 2015 came in at -$1.5 million, down 405.59% year-over-year; the trailing twelve-month figure through Mar 2016 was -$1.5 million (up 22.18% YoY), and the FY2015 annual result was $2.4 million, up 310.25% from the prior year.
- Income from Non-Controlling Interests came in at -$1.5 million for Q2 2015 at Ligand Pharmaceuticals, down from -$843000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$304000.0 in Q2 2014 to a low of -$1.5 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -1.54 Mn |
| Mar 31, 2015 | -843,000.00 |
| Dec 31, 2014 | -325,000.00 |
| Sep 30, 2014 | -503,000.00 |
| Jun 30, 2014 | -304,000.00 |